Shuangqi Cai

891 citations
19 papers · 668 indexed · h-index 11
Topics
Bacterial biofilms and quorum sensing (6 papers)Antibiotic Resistance in Bacteria (5 papers)MicroRNA in disease regulation (3 papers)
Partner nations
ChinaAustraliaIndia

In The Last Decade

Shuangqi Cai

18 papers receiving 662 citations

Peers

Shuangqi Cai
Comparison fields: 5 of 81
  • Molecular Biology 390
  • Molecular Medicine 117
  • Pharmacology 75
  • Infectious Diseases 74
  • Pulmonary and Respiratory Medicine 70
Replace Jinliang Kong with:
Jinliang Kong China
Yong‐Bin Eom South Korea
Padmani Sandhu India
Khaled H. Abd El Galil Egypt
Saman Soleimanpour Iran
Dorota Wojnicz Poland
Momen Askoura Egypt
Wanxin Li China
Garima Sharma India
Venkadesaperumal Gopu India
Shuangqi Cai relative to Jinliang Kong China Jinliang Kong's profile →
Citations per field
00.5×1.5×
Jinliang Kong · 1×
Citations per year

Countries citing papers authored by Shuangqi Cai

Since Specialization
Citations

This map shows the geographic impact of Shuangqi Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuangqi Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuangqi Cai more than expected).

Fields of papers citing papers by Shuangqi Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuangqi Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuangqi Cai. The network helps show where Shuangqi Cai may publish in the future.

Co-authorship network of co-authors of Shuangqi Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Shuangqi Cai. A scholar is included among the top collaborators of Shuangqi Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuangqi Cai. Shuangqi Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 1
2 21
3 5
4 14
5 1
6 0
7 27
8 19
9 32
10 254
11 38
12 34
13 138
14 9
15 8
16 5
17 23
18 38
19
Engineered bacterial Fc receptors.
1

About Shuangqi Cai

Shuangqi Cai is a scholar working on Molecular Medicine, Periodontics and Cancer Research, having authored 19 papers that have together received 668 indexed citations. Recurring topics across this work include Bacterial biofilms and quorum sensing (6 papers), Antibiotic Resistance in Bacteria (5 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Molecular Medicine (117 citations), Microbiology (70 citations) and Endocrinology (53 citations). Shuangqi Cai has collaborated with scholars based in China, Australia and India. Frequent co-authors include Jinliang Kong, Ke Wang, Tangjuan Liu, Biying Dong, Jing Luo, Danqing Lei, Xiaojing Cheng, Yanling Chen, Yanan Li and Yiqiang Chen. Their work appears in journals such as PLoS ONE, Chemical Engineering Journal and Advanced Healthcare Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026